Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The most effective method to Pick the Right Teeth Substitution Choice for You16.10.2023 - 2IDF, police arrest eleven for criminal, terror-related activity over weekend06.12.2025
- 3People are getting their news from AI – and it’s altering their views19.12.2025
- 4Favored Organic product for Seniors' Prosperity: Make Your Determination05.06.2024
- 5Figure out how to Consolidate All encompassing Practices with a Degree in Brain research17.10.2023
- One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
- Instructions to Figure out the Various Phases of Cellular breakdown in the lungs
- Fundamental Archives for Beginning Your Business
- Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- Select Your Definitive Pizza Decision
- The Most Famous Virtual Entertainment Powerhouses of the Year
- The moon and sun figure big in the new year's lineup of cosmic wonders
- Blood pressure drug recalled for possible cross-contamination
- Step by step instructions to Remain Spurred While Chasing after a Web-based Degree
